Visiopharm and Omnyx Partner to Advance Cancer Diagnostics with Clinically Validated Image Analysis Algorithms for Pathologists

Visiopharm and Omnyx Partner to Advance Cancer Diagnostics with Clinically Validated Image Analysis Algorithms for Pathologists
Hoersholm, Denmark (PRWEB) October 15, 2013 Visiopharm a leader in Quantitative Digital Pathology and Omnyx LLC, a joint venture between GE Healthcare and UPMC a leader in digital pathology, partner to advance cancer diagnostics with clinically vali...
Read more

Danish Pathologists Embrace New Standards in Cancer Diagnostics on a National Scale

Danish Pathologists Embrace New Standards in Cancer Diagnostics on a National Scale
There is a pressing need to improve and standardize the diagnostic work on cancer in order to optimize patient care.  In Denmark, the healthcare system and pathology departments, face major challenges.  These include too few experienced pa...
Read more